Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Arai, Nana"" wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł :
Elevated C-reactive protein level is associated with poor prognosis in follicular lymphoma patients undergoing rituximab-containing chemotherapy.
Autorzy :
Kawaguchi Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan. .
Saito B; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Nakata A; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Matsui T; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Sasaki Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Shimada S; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Abe M; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Watanuki M; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Baba Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Murai S; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Arai N; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Fujiwara S; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Kabasawa N; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Tsukamoto H; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Uto Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Yanagisawa K; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Hattori N; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Harada H; Division of Hematology, Department of Medicine, Showa University Fujigaoka Hospital, Kanagawa, Japan.
Nakamaki T; Division of Hematology, Department of Medicine, Showa University School of Medicine, 142-8666 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, Japan.
Pokaż więcej
Źródło :
International journal of hematology [Int J Hematol] 2020 Sep; Vol. 112 (3), pp. 341-348. Date of Electronic Publication: 2020 Jun 10.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
C-Reactive Protein/*analysis
Lymphoma, Follicular/*diagnosis
Lymphoma, Follicular/*drug therapy
Rituximab/*administration & dosage
Adult ; Aged ; Aged, 80 and over ; Biomarkers/blood ; Female ; Fibrinogen/analysis ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Prognosis ; Retrospective Studies ; Rituximab/therapeutic use
Czasopismo naukowe
Tytuł :
[Development of cardiac tamponade and emergence of arrhythmia during chemotherapy for diffuse large B-cell lymphoma].
Autorzy :
Baba Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Saito B; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Shimada S; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Sasaki Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Murai S; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Abe M; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Fujiwara S; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Arai N; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Kawaguchi Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Kabasawa N; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Tsukamoto H; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Uto Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Yanagisawa K; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Hattori N; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Harada H; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Nakamaki T; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Pokaż więcej
Źródło :
[Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2019; Vol. 60 (6), pp. 577-581.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Cardiac Tamponade/*chemically induced
Heart Neoplasms/*complications
Lymphoma, Large B-Cell, Diffuse/*complications
Aged ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Arrhythmias, Cardiac ; Heart Neoplasms/drug therapy ; Humans ; Lymphoma, Large B-Cell, Diffuse/drug therapy ; Male ; Pericardial Effusion
Czasopismo naukowe
Tytuł :
Efficacy of palonosetron to prevent delayed nausea and vomiting in non-Hodgkin's lymphoma patients undergoing repeated cycles of the CHOP regimen.
Autorzy :
Saito B; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan. .
Nakashima H; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Abe M; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Murai S; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Baba Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Arai N; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Kawaguchi Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Fujiwara S; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Kabasawa N; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Tsukamoto H; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Uto Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Ariizumi H; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Yanagisawa K; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Hattori N; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Harada H; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Nakamaki T; Division of Hematology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-Ku, Tokyo, 142-8666, Japan.
Pokaż więcej
Źródło :
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2018 Jan; Vol. 26 (1), pp. 269-274. Date of Electronic Publication: 2017 Aug 02.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Isoquinolines/*therapeutic use
Lymphoma, Non-Hodgkin/*drug therapy
Nausea/*chemically induced
Quinuclidines/*therapeutic use
Vomiting/*chemically induced
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/pharmacology ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/pharmacology ; Cyclophosphamide/therapeutic use ; Doxorubicin/administration & dosage ; Doxorubicin/pharmacology ; Doxorubicin/therapeutic use ; Female ; Humans ; Isoquinolines/administration & dosage ; Isoquinolines/pharmacology ; Male ; Middle Aged ; Palonosetron ; Prednisone/administration & dosage ; Prednisone/pharmacology ; Prednisone/therapeutic use ; Prospective Studies ; Quinuclidines/administration & dosage ; Quinuclidines/pharmacology ; Vincristine/administration & dosage ; Vincristine/pharmacology ; Vincristine/therapeutic use ; Young Adult
SCR Protocol :
CHOP protocol
Czasopismo naukowe
Tytuł :
[Syndrome of inappropriate secretion of antidiuretic hormone in multiple myeloma patients treated with bortezomib, lenalidomide, and dexamethasone combination therapy].
Autorzy :
Baba Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Harada H; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Shimada S; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Sasaki Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Murai S; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Abe M; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Fujiwara S; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Arai N; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Kawaguchi Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Kabasawa N; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Tsukamoto H; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Uto Y; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Ariizumi H; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Yanagisawa K; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Hattori N; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Saito B; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Nakamaki T; Division of Hematology, Department of Medicine, Showa University School of Medicine.
Pokaż więcej
Źródło :
[Rinsho ketsueki] The Japanese journal of clinical hematology [Rinsho Ketsueki] 2018; Vol. 59 (11), pp. 2423-2427.
Typ publikacji :
Journal Article
MeSH Terms :
Inappropriate ADH Syndrome*/chemically induced
Multiple Myeloma*/drug therapy
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Bortezomib/administration & dosage ; Bortezomib/adverse effects ; Dexamethasone/administration & dosage ; Dexamethasone/adverse effects ; Female ; Humans ; Lenalidomide/administration & dosage ; Lenalidomide/adverse effects
Czasopismo naukowe
Tytuł :
CD200 Expression on Plasma Cell Myeloma Cells is Associated with the Efficacies of Bortezomib, Lenalidomide and Thalidomide.
Autorzy :
Tazawa S; Department of Pathology and Laboratory Medicine, Showa University School of Medicine.
Shiozawa E
Homma M
Arai N
Kabasawa N
Kawaguchi Y
Fujiwara S
Okino K
Kobayashi K
Yamochi T
Tate G
Nakamaki T
Takimoto M
Pokaż więcej
Źródło :
Journal of clinical and experimental hematopathology : JCEH [J Clin Exp Hematop] 2015; Vol. 55 (3), pp. 121-6.
Typ publikacji :
Journal Article
MeSH Terms :
Antigens, CD/*metabolism
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Multiple Myeloma/*drug therapy
Multiple Myeloma/*metabolism
Adult ; Aged ; Aged, 80 and over ; Antigens, CD/genetics ; Biomarkers ; Bortezomib/administration & dosage ; Female ; Gene Expression ; Humans ; Immunohistochemistry ; Lenalidomide ; Male ; Middle Aged ; Multiple Myeloma/diagnosis ; Multiple Myeloma/mortality ; Neoplasm Staging ; Prognosis ; Survival Analysis ; Thalidomide/administration & dosage ; Thalidomide/analogs & derivatives ; Treatment Outcome
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies